LetterLetter
MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill?
P.F. Høilund-Carlsen, A. Alavi, G. Perry and J.R. Barrio
American Journal of Neuroradiology December 2022, DOI: https://doi.org/10.3174/ajnr.A7702
P.F. Høilund-Carlsen
aDepartment of Clinical ResearchUniversity of Southern DenmarkOdense, Denmark
A. Alavi
bDepartment of RadiologyPerelman School of MedicineUniversity of PennsylvaniaPhiladelphia, Pennsylvania
G. Perry
cDepartment of Neuroscience, Developmental and Regenerative BiologyUniversity of Texas at San AntonioSan Antonio, Texas
J.R. Barrio
dDavid Geffen UCLA School of Medicine at UCLALos Angeles, California

Jump to comment:
No eLetters have been published for this article.
Advertisement
P.F. Høilund-Carlsen, A. Alavi, G. Perry, J.R. Barrio
MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill?
American Journal of Neuroradiology Dec 2022, DOI: 10.3174/ajnr.A7702
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement